8-K

Company

Dianthus Therapeutics, Inc. /DE/

Filed

March 9, 2026

Period of Report

March 9, 2026

Accession Number

0001193125-26-097555

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →